Abnormal immunoglobulin synthesis in monoclonal immunoglobulin light chain and light and heavy chain deposition disease

被引:16
|
作者
Buxbaum, JN [1 ]
机构
[1] Scripps Res Inst, New York VA Med Ctr, Res Serv, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[2] NYU, Sch Med, Kaplan Canc Ctr, New York, NY USA
[3] NYU, Sch Med, New York VA Med Ctr, Res Serv,Dept Med, New York, NY USA
[4] NYU, Sch Med, New York VA Med Ctr, Res Serv,Dept Pathol, New York, NY USA
来源
关键词
AH amyloidosis; amyloidosis; HCDD; immunoglobulins; LCDD; LHCDD; AL amyloidosis; MIDD;
D O I
10.3109/13506120109007349
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Congo red-binding fibrils of AL amyloidosis are the most common form of monoclonal immunoglobulin tissue deposition (MIDD). Nonetheless, the less structured deposits found in light chain deposition disease (LCDD) and the similar, but distinct, deposits of light and heavy chain deposition disease (LHCDD) and heavy chain deposition disease (HCDD) can produce significant clinical pathology. Analyses of immunoglobulin synthesis by bone marrow cells obtained from 7 patients with LCDD and LHCDD demonstrated the production of excess light chains in all and the presence of incomplete light chains or heavy chain fragments in 5, regardless of the presence of an intact monoclonal protein or related subunit in the serum or urine. Our data indicate that, as is the case with the fibrillar deposits of AL amyloid, the non-fibrillar forms of monoclonal Ig deposition (LCDD and LHCDD) can be associated with the presence of immunoglobulin fragments in bone marrow cells. In some instances these appeared to be synthetic in origin, although rapid intracellular proteolysis or ii combination of both could not be excluded. In either case the fragments may be more susceptible to tissue deposition, with subsequent organ compromise, than intact Ig chains.
引用
收藏
页码:84 / 93
页数:10
相关论文
共 50 条
  • [21] A NEW NEPHROPATHY - IMMUNOGLOBULIN LIGHT CHAIN DISEASE
    APARICIO, M
    POTAUX, L
    BOUCHET, JL
    BEZIAN, JH
    [J]. PRESSE MEDICALE, 1988, 17 (44): : 2325 - 2327
  • [22] Intact immunoglobulin heavy/light chain paired assays
    Harding, Stephen
    Young, Philip
    Di Fazio, Marina
    Hughes, Richard
    [J]. BIOCHIMICA CLINICA, 2013, 37 (05) : 365 - 369
  • [23] Immunoglobulin A Heavy Chain Deposition Disease: A Case Report
    Chen, Qian
    Ye, Jun Bing
    Zhong, Qing
    [J]. IRANIAN JOURNAL OF KIDNEY DISEASES, 2021, 15 (06) : 457 - 460
  • [24] Domain stability in immunoglobulin light chain deposition disorders
    Wetzel, R
    [J]. ADVANCES IN PROTEIN CHEMISTRY, VOL 50: PROTEIN MISASSEMBLY, 1997, 50 : 183 - 242
  • [25] A case of monoclonal immunoglobulin light- and heavy-chain deposition disease exhibiting atypical deposition with fibrillary structures, successfully treated with chemotherapy
    Nakatsuka, A
    Maeshima, Y
    Sarai, A
    Yanai, H
    Sugiyama, H
    Yamasaki, Y
    Makino, H
    [J]. CLINICAL NEPHROLOGY, 2005, 64 (03) : 221 - 227
  • [26] BiP and immunoglobulin light chain cooperate to control the folding of heavy chain and ensure the fidelity of immunoglobulin assembly
    Lee, YK
    Brewer, JW
    Hellman, R
    Hendershot, LM
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1999, 10 (07) : 2209 - 2219
  • [27] IMMUNOGLOBULIN LIGHT CHAIN NEPHROPATHIES
    STURGILL, BC
    TUCKER, FL
    BOLTON, WK
    [J]. PATHOLOGY ANNUAL, 1987, 22 : 133 - 150
  • [28] The mysterious immunoglobulin light chain
    Pilström, L
    [J]. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2002, 26 (02): : 207 - 215
  • [29] REFOLDING OF THE IMMUNOGLOBULIN LIGHT CHAIN
    GOTO, Y
    AZUMA, T
    HAMAGUCHI, K
    [J]. JOURNAL OF BIOCHEMISTRY, 1979, 85 (06): : 1427 - 1438
  • [30] IMMUNOGLOBULIN LIGHT CHAIN GENES
    ZACHAU, HG
    [J]. FRESENIUS ZEITSCHRIFT FUR ANALYTISCHE CHEMIE, 1986, 324 (3-4): : 202 - 202